RCT | Valbenazine outperforms placebo in alleviating chorea in Huntington’s disease

Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington’s disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial – The Lancet Neurology (link to abstract – $ for full-text)

News Release: Valbenazine improves chorea associated with Huntington’s disease – News Medical / University of Texas Health Science Center at Houston